Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Vext Science ( (TSE:VEXT) ) has shared an update.
Vext Science, Inc. announced it will release its Q1 2025 financial results on May 21, 2025, before the market opens. The company will also host a conference call and webcast to discuss these results, reflecting its continued focus on growth and stakeholder engagement in its core markets of Arizona and Ohio.
The most recent analyst rating on (TSE:VEXT) stock is a Buy with a C$0.50 price target. To see the full list of analyst forecasts on Vext Science stock, see the TSE:VEXT Stock Forecast page.
Spark’s Take on TSE:VEXT Stock
According to Spark, TipRanks’ AI Analyst, TSE:VEXT is a Neutral.
Vext Science’s overall score reflects significant challenges in financial performance, with profitability and cash flow issues weighing heavily. While the company shows potential with strategic expansions in Ohio and positive earnings call highlights, weak technical indicators and poor valuation metrics limit the stock’s attractiveness. Continued focus on operational efficiency and cash flow generation will be key to improving its financial health.
To see Spark’s full report on TSE:VEXT stock, click here.
More about Vext Science
Vext Science, Inc. is a U.S.-based cannabis operator with vertical operations in Arizona and Ohio, specializing in cultivation, manufacturing, and retail. The company is known for its Vapen™ brand, which includes THC concentrates, edibles, and distillate cartridges, and has been operating profitably since 2016.
Average Trading Volume: 92,469
Technical Sentiment Signal: Sell
Current Market Cap: C$26M
For an in-depth examination of VEXT stock, go to TipRanks’ Stock Analysis page.